Targeted delivery of antisense oligonucleotides in cancer

Journal of Controlled Release

Volumn 74, Issue 1-3, 2001, Pages 69-75

  Pastorino, F ^a   Stuart, D ^a   Ponzoni, M ^b   Allen, T M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Anti GD2; Antisense oligonucleotides; Liposomes; Melanoma; Targeted drug delivery

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; LIPID; LIPOSOME; MONOCLONAL ANTIBODY;

ANTINEOPLASTIC ACTIVITY; CELL INTERACTION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; NEUROBLASTOMA; NEUROBLASTOMA CELL; ONCOGENE C MYB; ONCOGENE C MYC; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL;

BLOTTING, WESTERN; CELL DIVISION; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; MICELLES; NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-MYC; TUMOR CELLS, CULTURED;

EID: 0035816155     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(01)00312-1     Document Type: Conference Paper

References (17)

1. Antisense oligonucleotides as therapeutic agents - Is the bullet really magical?
2. Inhibition of protooncogenes expression by antisense oligodeoxynucleotides: Biological and therapeutic implications
3. Antimessenger oligodeoxyribonucleotides: An alternative to antisense RNA for artificial regulation of gene expression - A review
4. Antisense oligodeoxynucleotides as clinical therapeutic agents
5. Physicochemical properties of phosphorothioate oligodeoxynucleotides
6. Therapeutic applications of oligonucleotides
7. Mechanism of oligonucleotide release from cationic liposomes
8. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides
9. A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability
10. A comparison of in vivo gene delivery methods for antisense therapy in ligament healing
11. Inhibition of HIV-I replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes
12. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system
13. A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1
14. In vitro and in vivo targeting of immunoliposomal doxorubicin to human b-cell lymphoma
15. GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinide
16. Immunoliposome-mediated targeting of anti-cancer drugs in vivo
17. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD2-targeted immunoliposomes: Antitumor effects